AGI.do

Industries

What will AGI do for Research and Development in Biotechnology (except Nanobiotechnology)?

This U.S. industry comprises establishments primarily engaged in conducting biotechnology (except nanobiotechnology) research and experimental development. Biotechnology (except nanobiotechnology) research and experimental development involves the study of the use of microorganisms and cellular and biomolecular processes to develop or alter living or non-living materials. This research and development in biotechnology (except nanobiotechnology) may result in development of new biotechnology (except nanobiotechnology) processes or in prototypes of new or genetically-altered products that may be reproduced, utilized, or implemented by various industries. Illustrative Examples: Cloning research and experimental development laboratories DNA technologies (e.g., microarrays) research and experimental development laboratories Nucleic acid chemistry research and experimental development laboratories Protein engineering research and experimental development laboratories Recombinant DNA research and experimental development laboratories Cross-References. Establishments primarily engaged in--

How AGI delivers it

Four ways AGI delivers for Research and Development in Biotechnology (except Nanobiotechnology)

  • Business-as-Code

    Encode how your work runs, once, as software that executes itself.

    For Research and Development in Biotechnology (except Nanobiotechnology), encode how your work runs, once, as software that executes itself.

  • Autonomous Agents as digital employees

    Hire a digital employee that does the job under earned, supervised autonomy.

    For Research and Development in Biotechnology (except Nanobiotechnology), hire a digital employee that does the job under earned, supervised autonomy.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Research and Development in Biotechnology (except Nanobiotechnology), get the professional outcome delivered as software, priced on results, not headcount.

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Research and Development in Biotechnology (except Nanobiotechnology), give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

Go deeper

Explore Research and Development in Biotechnology (except Nanobiotechnology)

Read the deeper take on agi.asView as markdown